Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPS-Select for Transitional Pain Service in High-Risk Surgical Patients
NCT07296770Phase 3Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial, sponsored by University of California, San Francisco. Primary endpoint: Presence of Chronic Post-Surgical Pain at 90 days. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07296770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296770.